July 22 Could Ignite a Financial Nightmare

He said “a major reckoning is coming” 3 months before 2025’s crash… his work pointed to the Covid crash 25 days before stocks bottomed… and his firm spends $8 million a year in search of the biggest declines in the stock market. Now – one man has a chilling warning for the financial system on July 22.

Tue, July 22 at 10:00AM ET
 
 
 
 

Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Don’t Rush Into Roblox Stock Just Yet

RBLX stock has been an early winner. But investors need to consider what the platform looks like going forward — and what the price says now.

Old-Tech Oracle Needs to Embrace New Tech

Old tech-software giant Oracle has a fighting chance to be a leader in new tech, but ORCL stock appears to be fairly valued here.

IBM Earnings Preview: What Growth Investors Can Learn From Big Blue

IBM reports Q1 earnings tonight after the close. Don't expect much sizzle for IBM stock, but some of what Big Blue says tonight matters for growth investors.

At This Level, Risky Canoo Stock May Be Appealing to Hyper-Growth Investors

Canoo's recent earnings call dealt some serious blows to its growth thesis, leaving GOEV stock quite risky.

Clover Health Investments Isn’t a Long-Term Stock Despite Proof of Concept

CLOV stock has followed the traditional SPAC boom-and-bust cycle. However, it's still not low enough to call it a viable investment.

Will Biden’s Infra Plan Make Chargepoint Holdings Stock Great Again?

President Biden's American Jobs Plan has provided excitement in the EV charging space, but what impact will competition have on CHPT stock?

CPNG Stock Looks to Be Retreating, but It Hasn’t Fallen Far Enough Yet

Investors in CPNG stock have seen a marked decline from the stock price Coupang traded at immediately following its IPO in March.

3 Stocks That Prove We’re in a Bubble

Expect a bumpy ride this earnings season. Here are some market ingredients that suggest we’re in bubble territory -- and 3 potential targets.

Riot Blockchain Blows Through Numbers, Implying the Stock Could Rise

Overall, Riot Blockchain blows through numbers -- implying RIOT stock could rise to new heights for these reasons.

Paysafe Has a Bright Future, But PSFE Stock? Not So Much

Paysafe is a strong, reputable company. However, the upside on PSFE stock is limited until it can grow into its excessive enterprise value.

Hold Off on Palantir Stock Until Enthusiasm Returns

Considering that it will take years for PLTR stock to grow into its valuation, buying now while interest fades probably isn't worthwhile.

Tilray-Aphria Merger Is Positive, But the Outlook Remains Cloudy

Tilray's upcoming merger with Aphria is a great move. However, profitability is still a long way off and TLRY stock may struggle.

Shopify Stock Drops on News of C-Suite Exodus, But There’s No Need to Panic

After a stellar 2020, SHOP stock is struggling in 2021 for several reasons. But for some investors, that means attractively priced shares.

Don’t Be Too Quick to Book American Airlines in Your Portfolio

AAL stock seems like an excellent long-term opportunity based on higher passenger volume, but some details are contradictory.

Roblox Is a Metaverse Play Worth Holding for the Long Haul

Roblox’s “metaverse” is a major hit in the gaming community. Here’s why RBLX stock is a great investment for the long haul.

Castor Maritime Has Gotten Way Ahead Of Itself At This Point

CTRM stock is incredibly overvalued compared to its peers and is unattractive without a major price correction

7 High-Risk Stocks Banking on a Return to Normal

These seven risky stocks might take a breather as the bull market enters a more speculative stage in the new quarter. Proceed with caution.

The Risks Behind the Big Opportunity in ChargePoint Stock

CHPT stock has struggled amid what looks like an EV bust. Q4 earnings and the longer-term outlook could explain why.

Despite Recent Progress, Zomedica Has to Prove Its Value

Despite releasing Truforma ahead of schedule, Zomedica still has to overcome tough challenges facing the product. Investors should not buy ZOM stock yet.